Author

Julian Gilljam

Düsseldorf University Hospital

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cell Biology· 1 Systems Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Assay:bulk RNA-seq· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:differential expression· 1 Organism:human· 1 Assay:metabolomics· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

Anne T. SchneideriD· 1 shared Bernhard Willibald RenziD· 1 shared Carolin AngendohriD· 1 shared Chenjun HuangiD· 1 shared Christiane Koppe· 1 shared Chunfang GaoiD· 1 shared Diran Agaid HerebianiD· 1 shared Donato InversoiD· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperSystems Biology

Anne T. SchneiderORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Transient suppression of the ECM1 gatekeeper is essential for HGF/c-MET-driven liver regeneration

Ye Yao, Yujia Li, Chenjun Huang, Jiayi Ma, Liang Xu, Stephanie D. Wolf, Julian Gilljam, Haifeng Zeng, Stefan Munker, Xioachun Cao-Ehlker, Ruochan Li, Bernhard Willibald Renz, Hanno Nieß, Seddik Hammad, Elisa Holstein, , Sai Wang

This study identifies ECM1 as a gatekeeper that transiently suppresses HGF activity during liver regeneration, enabling tissue repair through c-MET-ERK-MYC signaling.

bioRxiv · Jun 10, 2026 · PreprintCell Biology

The ferroptosis mediator ACSL4 fails to prevent disease progression in mouse models of MASLD

Carolin Angendohr, Christiane Koppe, Diran Agaid Herebian, Anne T. Schneider, Leonie S. Keysberg, Michael T. Singer, Julian Gilljam, Matthias A. Dille, Johannes Georg Bode, Sebastian G. Doll, Marcus Conrad, Mihael Vucur, Tom Luedde

This study investigates whether ACSL4 deletion in liver cells prevents MASLD progression in mice but finds no significant differences compared to wild-type mice.

Hepatology Communications · May 16, 2025Peer-reviewedSystems Biology